## Abstract ## Aim The aim of the study was to determine whether the clinical benefits of galantamine for patients with Alzheimer's disease lead to benefits for caregivers. ## Methods Data were pooled from two concurrent, multiβcentre, randomized, doubleβblind, placeboβcontrolled, 6βmonth trials
β¦ LIBER β¦
Alzheimer's disease and caregiver time
β Scribed by MichaelJ. Moore; ElizabethC. Clipp
- Book ID
- 118554966
- Publisher
- The Lancet
- Year
- 1994
- Tongue
- English
- Weight
- 334 KB
- Volume
- 343
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of galantamine treatment on
β
Mary Sano; Gordon K. Wilcock; Bart van Baelen; Shane Kavanagh
π
Article
π
2003
π
John Wiley and Sons
π
English
β 92 KB
π 2 views
Caregiver time and cost of informal care
β
Huali Wang; Tianfei Gao; Xin Yu
π
Article
π
2010
π
Elsevier Science
π
English
β 43 KB
Caregiver Time and Cost of Home Care for
β
Huali Wang; Tianfei Gao; Anders Wimo; Xin Yu
π
Article
π
2010
π
Springer-Verlag
π
English
β 164 KB
The Caregiver Activity Survey (CAS): lon
β
Deborah B. Marin; Micheline Dugue; James Schmeidler; Jennifer Santoro; Judith Ne
π
Article
π
2000
π
John Wiley and Sons
π
English
β 85 KB
π 2 views
Family members incur substantial \_nancial costs during the course of caring for an individual with Alzheimer|s disease[ Much of this cost is associated with time spent in caregiving tasks\ including supervision and communication with the patient\ and assisting with activities of daily living[ We ha
Caregiver burden in Alzheimer's disease
β
Diane Ito; Jonathan Stokes; Elizabeth Piault-Louis; Patrick Bonnet
π
Article
π
2010
π
Elsevier Science
π
English
β 42 KB
Alzheimer's Disease: Diary of a Caregive
β
Carla Wilhoite; Mary Beth T. Buschmann
π
Article
π
1991
π
John Wiley and Sons
π
English
β 427 KB